Search Results - "Kizlaitienė, Rasa"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    Chronotypes and their relationship with depression, anxiety, and fatigue among patients with multiple sclerosis in Vilnius, Lithuania by Jonušaitė, Ieva, Sakalauskaitė-Juodeikienė, Eglė, Kizlaitienė, Rasa, Giedraitienė, Nataša, Sereikė, Ieva, Liutkienė, Justina, Kaubrys, Gintaras, Jatužis, Dalius

    Published in Frontiers in neurology (27-11-2023)
    “…Approximately half of patients with multiple sclerosis (PWMS) experience sleep disorders or changes in the circadian rhythm, that may further promote the…”
    Get full text
    Journal Article
  2. 2

    The BICAMS Battery for Assessment of Lithuanian-Speaking Multiple Sclerosis Patients: Relationship with Age, Education, Disease Disability, and Duration by Giedraitienė, Nataša, Kizlaitienė, Rasa, Kaubrys, Gintaras

    Published in Medical science monitor (10-12-2015)
    “…BACKGROUND Assessment of cognitive impairment (CI) in multiple sclerosis (MS) patients is very useful, but it requires time-consuming expert evaluation with…”
    Get full text
    Journal Article
  3. 3

    Belief in omens and superstitions among patients with chronic neurological disorders by Mameniškienė, Rūta, Kizlaitienė, Rasa, Kaladytė Lokominienė, Rūta, Puteikis, Kristijonas

    Published in Frontiers in public health (2024)
    “…Chronic neurological disorders may affect various cognitive processes, including religiosity or superstitious belief. We investigated whether superstitious…”
    Get full text
    Journal Article
  4. 4

    Cognitive Decline in Multiple Sclerosis Is Related to the Progression of Retinal Atrophy and Presence of Oligoclonal Bands: A 5-Year Follow-Up Study by Giedraitiene, Natasa, Drukteiniene, Egle, Kizlaitiene, Rasa, Cimbalas, Andrius, Asoklis, Rimvydas, Kaubrys, Gintaras

    Published in Frontiers in neurology (13-07-2021)
    “…Background: Brain atrophy, which is associated with cognitive impairment and retinal nerve fiber layer (RNFL) atrophy, is the main biomarker of…”
    Get full text
    Journal Article
  5. 5

    Composite Marker of Cognitive Dysfunction and Brain Atrophy is Highly Accurate in Discriminating Between Relapsing-Remitting and Secondary Progressive Multiple Sclerosis by Kizlaitienė, Rasa, Kaubrys, Gintaras, Giedraitienė, Nataša, Ramanauskas, Naglis, Dementavičienė, Jūratė

    Published in Medical science monitor (01-02-2017)
    “…BACKGROUND With the advent of numerous new-generation disease-modifying drugs for multiple sclerosis (MS), the discrimination between relapsing-remitting MS…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Cognition During and After Multiple Sclerosis Relapse as Assessed With the Brief International Cognitive Assessment for Multiple Sclerosis by Giedraitiene, Natasa, Kaubrys, Gintaras, Kizlaitiene, Rasa

    Published in Scientific reports (25-05-2018)
    “…There is some evidence that cognition may be impaired during multiple sclerosis (MS) relapse. The aims of this study were to assess the cognitive status with…”
    Get full text
    Journal Article
  8. 8

    Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study by Kappos, Ludwig, Fox, Robert J, Wallström, Erik, Akman-Demir, Gulsen, Allen, Alison B, Applebee, Angela M, Balci, Belgin Petek, Barnett, Michael, Bass, Ann, Bejinariu, Mihaela, Bernitsas, Evanthia, Bhan, Virender, Boehringer, Matthias, Bracknies, Vera, Brescia Morra, Vincenzo, Brozman, Miroslav, Calkwood, Jonathan C, Cascione, Mark, Castelnovo, Giovani, Cooper, Joanna A, Corboy, John, Coyle, Patricia K, Craner, Matthew, Cunha, Luis, da Silva, Ana Martins, Deri, Norma H, Edan, Gilles, Elias, Stanton, Estruch, Bonaventura Casanova, Faiss, Juergen, Fedyanin, Alexander S, Fermont, Jiske, Fernandez, Oscar Fernandez, Ferrer, Francisco Coret, Ford, Corey, Gehring, Klaus, Gobbi, Claudio, Grandmaison, Francois, Grimaldi, Luigi Maria Edoardo, Haas, Judith, Harmjanz, Arndt, Herbert, Joseph, Hofmann, Werner E, Huang, Dehui, Huang, DeRen, Hupperts, Raymond, Karussis, Dimitrios, Khabirov, Farit A, Kister, Ilya, Krastev, Georgi, Lassek, Christoph, Laureys, Guy, Lee, Liesly, Li, Hongzeng, Linnebank, Michael, Maeurer, Mathias, Marfia, Girolama Alessandra, Meca-Lallana, Jose, Mihetiu, Ioan Gheorghe, Miller, Aaron E, Montoya, Lilina, Nakatsuji, Yuji, Nicholas, Richard, Nikfekr, Esmaeil, Odinak, Miroslav M, Olsson, Tomas, van Oosten, B W, Oreja-Guevara, Celia, Oschmann, Patrick, Pachner, Andrew, Panczel, Gyula, Pandolfo, Massimo, Pelletier, Jean, Piedrabuena, Raul, Rastenyte, Daiva, Rey, Roberto, Rozsa, Csilla, Rusek, Stanislaw, Saida, Takahiko, Salgado, Antonio Vasco, Sanders, Kalina, Schwab, Matthias, Scott, James, Shafer, Stuart, Shotekov, Penko, Siever, Arno, Sigel, Karl-Otto, Simu, Mihaela, Stangel, Martin, Stourac, Pavel, Tavernarakis, Antonios, Terzi, Murat, Ticmeanu, Marina, Tiel-Wilck, Klaus, Turcani, Peter, Valikovics, Attila, Weiss, Sara, Vermersch, Patrick, Yamamura, Takashi, Zacharias, Alan

    Published in The Lancet (British edition) (31-03-2018)
    “…No treatment has consistently shown efficacy in slowing disability progression in patients with secondary progressive multiple sclerosis (SPMS). We assessed…”
    Get full text
    Journal Article
  9. 9

    Autologous hematopoietic stem cell transplantation is superior to alemtuzumab in patients with highly active relapsing multiple sclerosis and severe disability by Vaisvilas, Mantas, Kaubrys, Gintaras, Kizlaitiene, Rasa, Taluntiene, Vera, Giedraitiene, Natasa

    Published in Multiple sclerosis and related disorders (01-12-2023)
    “…•Fewer relapses are established after HSCT than ATZ treatment.•ATZ may halt disability progression early in the course of highly active RMS.•After HSCT gradual…”
    Get full text
    Journal Article
  10. 10

    Working capacity level of patients with multiple sclerosis in Lithuania: Its dynamics and relationship with the employment and lethal outcomes by Valadkeviciene, Daiva, Jatuzis, Dalius, Kizlaitiene, Rasa, Zukauskaite, Irena, Venceviciene, Lina

    Published in Multiple sclerosis and related disorders (01-04-2021)
    “…•The paper demonstrates the dynamics of working capacity levels vs. employment of MS patients.•Age plays a significant role in impairing working capacity among…”
    Get full text
    Journal Article
  11. 11

    Incidence rate and sex ratio in multiple sclerosis in Lithuania by Valadkeviciene, Daiva, Kavaliunas, Andrius, Kizlaitiene, Rasa, Jocys, Mykolas, Jatuzis, Dalius

    Published in Brain and behavior (01-01-2019)
    “…Objectives To determine the temporal changes in incidence rates of multiple sclerosis (MS) over the past 15 years in Lithuania with prediction up to 2020, and…”
    Get full text
    Journal Article
  12. 12

    Therapeutic Plasma Exchange in Multiple Sclerosis Patients with Abolished Interferon-beta Bioavailability by Giedraitiene, Natasa, Kaubrys, Gintaras, Kizlaitiene, Rasa, Bagdonaite, Loreta, Griskevicius, Laimonas, Valceckiene, Vilma, Stoskus, Mindaugas

    Published in Medical science monitor (26-05-2015)
    “…Neutralizing antibodies (NAb) to interferon-beta (IFN-β) are associated with reduced bioactivity and efficacy of IFN-β in multiple sclerosis (MS). The…”
    Get full text
    Journal Article
  13. 13

    Biomechanical markers of impaired motor coordination by Daunoraviciene, Kristina, Ziziene, Jurgita, Griskevicius, Julius, Kizlaitiene, Rasa, Ovcinikova, Agne

    “…This study is devoted to movement analysis from a biomechanical perspective to evaluate coordination lesions. It aims to find the most characteristic…”
    Get full text
    Conference Proceeding
  14. 14

    Neurological diseases differentiation analysis using inertial measurement units by Luksys, Donatas, Kizlaitiene, Rasa, Kaubrys, Gintaras, Pakulaite, Gyte, Jatuzis, Dalius, Kaladyte-Lokominiene, Ruta, Buneviciute, Ramune, Griskevicius, Julius

    “…Human gait is cyclic process, which is affected by various neurological disorders like Parkinson's disease (PD) or multiple sclerosis (MS). Instrumented gait…”
    Get full text
    Conference Proceeding